Page last updated: 2024-08-26

bosentan anhydrous and Cardiac Hypertrophy

bosentan anhydrous has been researched along with Cardiac Hypertrophy in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (25.00)	18.2507
2000's	6 (50.00)	29.6817
2010's	2 (16.67)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Chen, Z; Deng, X; Li, W; Peng, Y; Wang, Y; Xiao, Y; Xiao, Z; Zeng, Y	1
Hoepf, TM; Holycross, BJ; McCune, SA; Radin, MJ	1
Janda, S; Quon, BS; Swiston, J	1
Cordaillat, M; Gaillard, V; Jover, B; Lartaud, I; Reboul, C; Rugale, C	1
Capuano, V; Coulombe, A; Deroubaix, E; Ferron, L; Renaud, JF; Ruchon, Y	1
Bäcker, A; Cervenka, L; Kramer, HJ; Opocensky, M; Vanêcková, I; Vernerová, Z	1
Bäcker, A; Cervenka, L; Dvorák, P; Eis, V; Kramer, HJ; Opocenský, M; Schejbalová, S; Vanecková, I; Vernerová, Z	1
Li, JS; Schiffrin, EL	1
Clozel, JP; Clozel, M; Gonzales, MF; Hess, P; Heudes, D; Karam, H; Löffler, BM	1
Bruneval, P; Clozel, JP; Clozel, M; Gonzales, MF; Heudes, D; Karam, H; Löffler, BM	1
Breu, V; Dechend, R; Ganten, D; Genersch, E; Haller, H; Löffler, BM; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Schneider, W	1
Belabbas, H; Herizi, A; Jover, B; Mimran, A	1

Reviews

1 review(s) available for bosentan anhydrous and Cardiac Hypertrophy

Article	Year
HIV and pulmonary arterial hypertension: a systematic review. HIV medicine, 2010, Volume: 11, Issue:10 Topics: Adolescent; Adult; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Bosentan; Cardiomegaly; CD4 Lymphocyte Count; Child; Cohort Studies; Confounding Factors, Epidemiologic; Databases, Bibliographic; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Electrocardiography; Epoprostenol; Female; Hemodynamics; HIV Infections; Humans; Hypertension, Pulmonary; Male; Prevalence; Radiography; Reverse Transcriptase Inhibitors; Sulfonamides; Survival Rate; Treatment Outcome	2010

Article

Year

HIV and pulmonary arterial hypertension: a systematic review.

HIV medicine, 2010, Volume: 11, Issue:10

Topics: Adolescent; Adult; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Bosentan; Cardiomegaly; CD4 Lymphocyte Count; Child; Cohort Studies; Confounding Factors, Epidemiologic; Databases, Bibliographic; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Electrocardiography; Epoprostenol; Female; Hemodynamics; HIV Infections; Humans; Hypertension, Pulmonary; Male; Prevalence; Radiography; Reverse Transcriptase Inhibitors; Sulfonamides; Survival Rate; Treatment Outcome

2010

Other Studies

11 other study(ies) available for bosentan anhydrous and Cardiac Hypertrophy

Article	Year
Ligation of patent ductus venosus in a child with pulmonary arterial hypertension and hypersplenism: A case report. Medicine, 2020, Aug-21, Volume: 99, Issue:34 Topics: Aftercare; Antihypertensive Agents; Bosentan; Cardiomegaly; Child, Preschool; Combined Modality Therapy; Echocardiography; Humans; Hypersplenism; Ligation; Male; Portal Vein; Pulmonary Arterial Hypertension; Radiography, Thoracic; Tadalafil; Tomography, X-Ray Computed; Treatment Outcome; Vascular Malformations; Vascular Resistance; Vasodilator Agents	2020
Salt-induced cardiac hypertrophy is independent of blood pressure and endothelin in obese, heart failure-prone SHHF rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2008, Volume: 30, Issue:7 Topics: Animals; Base Sequence; Blood Pressure; Bosentan; Cardiomegaly; DNA Primers; Endothelin Receptor Antagonists; Endothelins; Gene Expression; Heart Failure; Leptin; Male; Nitric Oxide Synthase; Obesity; Rats; RNA, Messenger; Sodium Chloride, Dietary; Sulfonamides	2008
Plasma volume and arterial stiffness in the cardiac alterations associated with long-term high sodium feeding in rats. American journal of hypertension, 2011, Volume: 24, Issue:4 Topics: Animals; Aorta, Thoracic; Blood Flow Velocity; Bosentan; Cardiomegaly; Echocardiography, Doppler; Endothelin Receptor Antagonists; Endothelin-1; Male; Plasma Volume; Pulsatile Flow; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Sulfonamides; Vascular Resistance	2011
Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circulation research, 2003, Dec-12, Volume: 93, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Bosentan; Butadienes; Calcium Channels, T-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Constriction, Pathologic; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Flavonoids; Gene Expression; Losartan; Male; Membrane Potentials; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Nickel; Nitriles; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Signal Transduction; Sulfonamides	2003
Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:4 Topics: Animals; Animals, Genetically Modified; Atrasentan; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Endothelin A Receptor Antagonists; Endothelin-1; Glomerulosclerosis, Focal Segmental; Heart Ventricles; Hypertension; Kidney; Male; Myocardium; Organ Size; Osmolar Concentration; Proteinuria; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride, Dietary; Sulfonamides; Survival Analysis	2005
Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats. Vascular pharmacology, 2006, Volume: 45, Issue:3 Topics: Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrasentan; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Glomerulosclerosis, Focal Segmental; Heterozygote; Hypertension; Male; Proteinuria; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renin; Sodium Chloride, Dietary; Sulfonamides; Time Factors	2006
Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:4 Pt 1 Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides	1995
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovascular research, 1996, Volume: 31, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Bosentan; Calcium Channel Blockers; Cardiomegaly; Collagen; Coronary Circulation; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Fibrosis; Hypertension; Male; Mibefradil; Myocardium; Perfusion; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes	1996
Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 28, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Benzimidazoles; Body Weight; Bosentan; Calcium Channel Blockers; Cardiomegaly; Coronary Circulation; Enalapril; Endothelins; Fibrosis; Heart Ventricles; Hemodynamics; Hormones; Hypertension; Kidney; Mibefradil; Myocardium; Rats; Rats, Inbred SHR; Sulfonamides; Tetrahydronaphthalenes	1996
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:2 Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiomegaly; Fibronectins; Heart; Humans; Hydralazine; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Macrophages; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides; Thromboplastin; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1	2000
[Cardiac and vascular hypertrophy in hypertension due to angiotensin II. Effect of losartan and bosentan]. Archives des maladies du coeur et des vaisseaux, 2000, Volume: 93, Issue:8 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Carotid Arteries; Endothelin Receptor Antagonists; Endothelins; Follow-Up Studies; Hypertension; Hypertrophy; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Sulfonamides	2000